Literature DB >> 14763169

Carcinoma of the cervix uteri.

J L Benedet1, F Odicino, P Maisonneuve, U Beller, W T Creasman, A P Heintz, H Y Ngan, S Pecorelli.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14763169     DOI： 10.1016/s0020-7292(03)90115-9

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  25 in total

1.  Neoadjuvant chemotherapy followed by radical surgery as an alternative treatment to concurrent chemoradiotherapy for young premenopausal patients with FIGO stage IIB squamous cervical carcinoma.

Authors:  ShanShan Yang; Ying Gao; Jing Sun; Bairong Xia; TianBo Liu; HongXia Zhang; Qi Li; Min Xiao; YunYan Zhang
Journal:  Tumour Biol       Date:  2015-01-21

2.  The upregulated expression of vascular endothelial growth factor in surgically treated patients with recurrent/radioresistant cervical cancer of the uterus.

Authors:  Kosuke Yoshida; Shiro Suzuki; Jun Sakata; Fumi Utsumi; Kaoru Niimi; Nobuhisa Yoshikawa; Kimihiro Nishino; Kiyosumi Shibata; Fumitaka Kikkawa; Hiroaki Kajiyama
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

3.  Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.

Authors:  Juan Wang; Tao Wang; Yun-Yi Yang; Yan-Lan Chai; Fan Shi; Z I Liu
Journal:  Mol Clin Oncol       Date:  2014-11-24

Review 4.  Postoperative radiation therapy for carcinoma of the uterine cervix.

Authors:  Takashi Uno; Koichi Isobe; Seiji Yamamoto; Tetsuya Kawata; Hisao Ito
Journal:  Radiat Med       Date:  2006-02

5.  Cost is a barrier to widespread use of liquid-based cytology for cervical cancer screening in Korea.

Authors:  Hyun Hoon Chung; Jae Weon Kim; Soon-Beom Kang
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

6.  Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma.

Authors:  Yuan Zhang; Yi Min Shu; Shu Fang Wang; Bang Hong Da; Ze Hua Wang; Hua Bin Li
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

7.  Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective study.

Authors:  Myong Cheol Lim; Jaeman Bae; Jeong-Yoel Park; Soyi Lim; Sokbom Kang; Sang-Soo Seo; Joo-Yong Kim; Ju-Won Rho; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

8.  Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells.

Authors:  Cheng-Jeng Tai; Jin-Wun Wang; Hou-Yu Su; Chen-Jei Tai; Chien-Kai Wang; Chun-Te Wu; Yung-Chang Lien; Yu-Jia Chang
Journal:  Tumour Biol       Date:  2013-08-09

9.  Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.

Authors:  T Kasamatsu; T Onda; M Sawada; T Kato; S Ikeda; Y Sasajima; H Tsuda
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity.

Authors:  Yuan Zhang; Yu Liu; Yuan-Xian Yang; Jia-Hong Xia; Hong-Xiu Zhang; Hua-Bin Li; Chun-Zhao Yu
Journal:  J Exp Clin Cancer Res       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.